Dr Jeremy Teoh is currently the Assistant Dean (External Affairs) and Associate Professor of the Faculty of Medicine, The Chinese University of Hong Kong (CUHK). He is also the Director of Urology Centre, and Director of Robotic Services, at the CUHK Medical Centre. In 2021, he was awarded the Ten Outstanding Young Persons Award (Hong Kong) and the SIU-Innovators Award. In 2023, he was appointed as an Adjunct Professor at the Medical University of Vienna. In 2024, he received the World Chinese Urological Society Rising Star Award.

Jeremy is an oncological surgeon with primary interest in bladder cancer. Previously, he conducted a randomised trial comparing between bipolar and monopolar transurethral resection of bladder tumour (TURBT) and showed that bipolar TURBT was able to achieve a higher detrusor sampling rate than monopolar TURBT. He has also developed a global consensus statement on en bloc resection of bladder tumour (ERBT). A total of 99 statements reached consensus and they have become the standard reference for urologists practising en bloc resection globally. Recently, he published the results of the EB-StaR study, which is a multi-centre randomised trial demonstrating that ERBT could reduce the 1-year recurrence rate from 38.1% to 28.5% for patients with ≤3cm non-muscle-invasive bladder cancer (NMIBC). He is also leading a phase 2 clinical trial on modified en bloc resection for large bladder tumours (>3cm). He is currently serving as a panel member of the European Association of Urology (EAU) Guidelines on NMIBC and Upper Tract Urothelial Carcinoma. He is an active member of the Urothelial Cancer Working Party, EAU Young Academic Urologists, and he is dedicated to high-quality research work in this area.

Jeremy has received numerous research grants with a total funding of more than 10 million USD. He has published more than 400 articles in peer-reviewed journals such as European Urology, European Urology Oncology, European Urology Focus and Nature Reviews Urology. He was the Chairperson of the Younger Fellows Chapter of the College of Surgeons of Hong Kong (2019-2021), the Chair of the Young Fellows Chapter of the Hong Kong Academy of Medicine (2021-2022), and he has been the Director of the Lions Kidney Educational Centre & Research Foundation since 2017. He is also the founder of the UroSoMe (Urology Social Media) working group and he believes that social media plays an important role in the modern era of medicine.